Literature DB >> 10473524

Deficient antibody-dependent cellular cytotoxicity against human immunodeficiency virus (HIV)-expressing target cells in perinatal HIV infection.

U Ziegner1, D Campbell, K Weinhold, I Frank, R Rutstein, S E Starr.   

Abstract

Peripheral blood mononuclear cells (PBMC) of human immunodeficiency virus (HIV)-infected children, age-matched HIV-seronegative controls, and HIV-infected asymptomatic and symptomatic adults were compared for their ability to mediate antibody-dependent cellular cytotoxicity (ADCC) and natural killer (NK) cell-mediated cytotoxicity against target cells expressing HIV or herpes simplex virus (HSV) antigens. Target cells consisted of CD4 lymphocytes purified from PBMC of HIV-seronegative adults and incubated with the IIIB strain of HIV, HUT78 cells chronically infected with IIIB, and HSV-infected human fibroblasts. PBMC of asymptomatic HIV-infected adults were generally able to lyse CD4 cells expressing HIV antigens. Direct correlation was found between the magnitude of lysis and absolute CD4 cell counts in these individuals. In contrast to these results, PBMC from HIV-infected children were generally unable to lyse IIIB-expressing CD4 cells, regardless of the children's clinical status, age, or absolute CD4 cell counts. Cells from HIV-seronegative adults and children did not directly lyse these target cells either but, in contrast to cells of HIV-seropositive children, were able to mediate cell lysis when serum from an HIV-seropositive adult was added. However, effector cells from these HIV-infected children were able to mediate both ADCC against HSV-infected fibroblasts and NK cell-mediated cytotoxicity against IIIB-infected HUT78 cells. Reduced ability of PBMC from vertically HIV-infected children to mediate ADCC against HIV antigen-expressing CD4 cells may contribute to rapid progression to AIDS.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10473524      PMCID: PMC95761          DOI: 10.1128/CDLI.6.5.718-724.1999

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  59 in total

1.  Persistent noncytopathic infection of normal human T lymphocytes with AIDS-associated retrovirus.

Authors:  J A Hoxie; B S Haggarty; J L Rackowski; N Pillsbury; J A Levy
Journal:  Science       Date:  1985-09-27       Impact factor: 47.728

2.  Analysis of effector mechanisms against HTLV-I- and HTLV-III/LAV-infected lymphoid cells.

Authors:  F W Ruscetti; J A Mikovits; V S Kalyanaraman; R Overton; H Stevenson; K Stromberg; R B Herberman; W L Farrar; J R Ortaldo
Journal:  J Immunol       Date:  1986-05-15       Impact factor: 5.422

3.  Effect of intravenous immune globulin on natural killer cell activity: possible association with autoimmune neutropenia and idiopathic thrombocytopenia.

Authors:  D Engelhard; J L Waner; N Kapoor; R A Good
Journal:  J Pediatr       Date:  1986-01       Impact factor: 4.406

4.  "Panning" for lymphocytes: a method for cell selection.

Authors:  L J Wysocki; V L Sato
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

5.  Natural killer cell function and modulation by alpha IFN and IL2 in AIDS patients and prodromal subjects.

Authors:  F Lew; P Tsang; S Solomon; I J Selikoff; J G Bekesi
Journal:  J Clin Lab Immunol       Date:  1984-07

6.  Effect of interleukin (IL)-12 and IL-15 on activated natural killer (ANK) and antibody-dependent cellular cytotoxicity (ADCC) in HIV infection.

Authors:  S J Lin; R L Roberts; B J Ank; Q H Nguyen; E K Thomas; E R Stiehm
Journal:  J Clin Immunol       Date:  1998-09       Impact factor: 8.317

7.  Circulating immune complexes in patients with acquired immune deficiency syndrome contain the AIDS-associated retrovirus.

Authors:  W J Morrow; M Wharton; R B Stricker; J A Levy
Journal:  Clin Immunol Immunopathol       Date:  1986-09

8.  Development of natural killer cell function in the human fetus.

Authors:  J Uksila; O Lassila; T Hirvonen; P Toivanen
Journal:  J Immunol       Date:  1983-01       Impact factor: 5.422

9.  Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. I. Characterization of the lymphocyte subset reactive with B73.1.

Authors:  B Perussia; S Starr; S Abraham; V Fanning; G Trinchieri
Journal:  J Immunol       Date:  1983-05       Impact factor: 5.422

10.  Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanism.

Authors:  A H Rook; J J Hooks; G V Quinnan; H C Lane; J F Manischewitz; A M Macher; H Masur; A S Fauci; J Y Djeu
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

View more
  6 in total

Review 1.  The role of infant immune responses and genetic factors in preventing HIV-1 acquisition and disease progression.

Authors:  C Farquhar; G John-Stewart
Journal:  Clin Exp Immunol       Date:  2003-12       Impact factor: 4.330

2.  A randomized placebo-controlled trial of massage therapy on the immune system of preterm infants.

Authors:  Jocelyn Y Ang; Jorge L Lua; Ambika Mathur; Ronald Thomas; Basim I Asmar; Sureyya Savasan; Steven Buck; Michael Long; Seetha Shankaran
Journal:  Pediatrics       Date:  2012-11-12       Impact factor: 7.124

Review 3.  Immunology of pediatric HIV infection.

Authors:  Nicole H Tobin; Grace M Aldrovandi
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

Review 4.  Tuberculosis Immune Reconstitution Inflammatory Syndrome in children initiating Antiretroviral Therapy for HIV infection: A systematic literature review.

Authors:  Ruth Link-Gelles; Harry Moultrie; Shobna Sawry; David Murdoch; Annelies Van Rie
Journal:  Pediatr Infect Dis J       Date:  2014-05       Impact factor: 2.129

Review 5.  Immunity to HIV in Early Life.

Authors:  Maximilian Muenchhoff; Andrew J Prendergast; Philip Jeremy Renshaw Goulder
Journal:  Front Immunol       Date:  2014-08-12       Impact factor: 7.561

6.  Early ART Results in Greater Immune Reconstitution Benefits in HIV-Infected Infants: Working with Data Missingness in a Longitudinal Dataset.

Authors:  Livio Azzoni; Russell Barbour; Emmanouil Papasavvas; Deborah K Glencross; Wendy S Stevens; Mark F Cotton; Avy Violari; Luis J Montaner
Journal:  PLoS One       Date:  2015-12-15       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.